MENU
+Compare
ELAB
Stock ticker: NASDAQ
AS OF
Jan 17 closing price
Price
$2.13
Change
-$0.02 (-0.93%)
Capitalization
6.55M

ELAB PMGC Holdings Inc Forecast, Technical & Fundamental Analysis

Industry Biotechnology
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ELAB with price predictions
Jan 08, 2025

Momentum Indicator for ELAB turns negative, indicating new downward trend

ELAB saw its Momentum Indicator move below the 0 level on January 06, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator turned negative. In of the 20 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELAB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ELAB advanced for three days, in of 40 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.765) is normal, around the industry mean (14.744). P/E Ratio (0.000) is within average values for comparable stocks, (88.252). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.853). ELAB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.215) is also within normal values, averaging (264.079).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ELAB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELAB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ELAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
120 Newport Center Drive
Phone
+1 866 794-4940
Employees
18
Web
https://www.elevailabs.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ECLCX28.940.35
+1.22%
Eaton Vance Growth C
LRAGX13.990.06
+0.43%
Lord Abbett International Growth R3
FSSZX38.700.15
+0.39%
Fidelity Advisor Stock Selector Sm Cp Z
ETCHX29.740.01
+0.03%
Eventide Healthcare & Life Sciences C
PJEAX15.34-0.06
-0.39%
PGIM US Real Estate A

ELAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ELAB has been loosely correlated with EPIX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ELAB jumps, then EPIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELAB
1D Price
Change %
ELAB100%
-0.93%
EPIX - ELAB
34%
Loosely correlated
N/A
PRAX - ELAB
22%
Poorly correlated
+0.41%
MTNB - ELAB
21%
Poorly correlated
+3.02%
REGN - ELAB
20%
Poorly correlated
-1.68%
LXRX - ELAB
20%
Poorly correlated
-3.28%
More